Research Group on Beta Cell Biology and Islet Transplantation : Islet xenotransplantation: recent progress and current perspectives
Thursday 13 October 15:00~17:00 | Place: Convention hall A
Chair: Kun-Ho Yoon
    • Over the last 15 years, islet allotransplantation has evolved into an established treatment for type 1 diabetic patients with hypoglycemic unawareness, and the procedure is currently reimbursed for this indication in several countries. However, human islet allotransplantation will never supply sufficient islets for the treatment of the many millions of patients with type 1 diabetes. Preliminary safety data obtained in recent pilot clinical trials, and preclinical safety and efficacy data obtained in the last 10 years in the stringent pig-to-nonhuman primate islet xenotransplantation setting, suggest that xenogeneic porcine islets can possibly be developed an alternative β-cell replacement therapy with broad applicability. In addition, the recent results reveal the potential impact of genetic modification of the xenogeneic islet donor and offer promise that an unlimited source of transplantable β-cells may be possible. In this session, recent progress and current perspective of islet xenotransplantation will be discussed.
Kwang-Won Kim Gachon University, Korea RG1-1 Why islet xenotransplantation in diabetes?
Chung-Gyu Park Seoul National University, Korea RG1-2 Islet xenotransplantation, past, present and future
Jee-Heon Jeong Yeungnam University, Korea RG1-3 Avoidance strategy for xeonogenic immune reaction using highly advanced surface modification technique
Eung Soo Hwang Seoul National University, Korea RG1-4 Xenotransplantation and zoonotic infection
Research Group on Clinical Data Standardization for Diabetes Research : Platforms for patient centered clinical research
Thursday 13 October 15:00~17:00 | Place: Convention hall B
Chair: Jeong Taek Woo
    • Recently, patient registration based clinical, and translational research such as Precision Medicine Initiative have been actively conducted in worldwide. In Korea, there have been managed several relevant systems for large-scale, multi-center, patient data registration and management. This session is organized to introduce major patient registration systems for diabetes and related metabolic diseases in Korea, and to spread relevant knowledge, knowhow, and information for cooperative research.
Hae Rim Choi National Research Institute of Health, Korea RG2-1 Introduction of iCReaT
Soo-Yong Shin Kyung Hee University, Korea RG2-2 ABLE: de-identified clinical data search, review, and extraction system
Sang Youl Rhee Kyung Hee University, Korea RG2-3 Introduction of KNDP data management house, KDMH
Research Group on Diabetic Neuropathy : Paradigm shift of management in diabetic peripheral neuropathy
Thursday 13 October 15:00~17:00 | Place: Convention hall C
Chair: Tae Sun Park
    • Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus (DM), affecting as many as 50% of patients with type 2 DM in Korea. Diabetic peripheral neuropathy involves the presence of symptoms or signs of peripheral nerve dysfunction and decreased quality of life in people with DPN. Management of DPN involves nonpharmacologic and pharmacologic approaches to minimize disease progression and relieve symptoms. This hot topic will be covered by 3 distinguished speakers and discussed with 3 experts as panelists.
Jee Youn Moon Seoul National University, Korea RG3-1 Nonpharmacologic approach for managing diabetic polyneuropathy
Jee Young Oh Konkuk University, Korea RG3-2 Current update on pharmacologic management of diabetic neuropathy
Chong Hwa Kim Sejong General Hospital, Korea RG3-3 Comprehensive management of intractable DPN
Ji Hyun Lee Daegu Catholic University, Korea RG3-Panel 1  
Jung Min Lee The Catholic University of Korea, Korea RG3-Panel 2  
Mi Kyoung Park Dong-A University, Korea RG3-Panel 3  
Research Group on Genetics : Genomics at the out-front of patient care
Thursday 13 October 15:00~17:00 | Place: Emerald Hall A
Chair: Sung-Hoon Kim
    • Genome analysis techniques using next generation sequencing and genome-wide association studies have made great strides in the past 10 years. Using these technique, extensive research has been conducted on the genetic predisposition for diabetes. It is widely accepted that genomic information will be a critical component of precision medicine in a very near future. The KDA interest group on genetics organized a meeting to share the results and experiences from the recent studies by the researchers on the out-front of such advancement. Dr. Soo-Heon Kwak at Seoul National University Hospital will share his experience on using whole exome sequencing for diagnosis of monogenic diabetes. Dr. Richard M. Watanabe at Keck School of Medicine of University of Southern California will give a lecture on current research on genetics of diabetes. Dr. Young Seok Ju at Korea Advanced Institute of Science and Technology will present on genetic investigation using mitochondrial DNA variation. Finally, Dr. Joohon Sung at Seoul National University will present his latest work on characteristics of Apolipoprotein gene clusters on chromosome 11 and the association with plasma triglyceride level. The four speakers will share their recent works as well as their views on incorporating genetic information in clinical research and practice.
Soo Heon Kwak Seoul National University, Korea RG4-1 Clinical whole exome sequencing in early onset diabetes patients
Richard M. Watanabe University of Southern California, USA RG4-2 The physiology consequences of genetic variation in type 2 diabetes: the substrate balance hypothesis
Young Seok Ju KAIST, Korea RG4-3 Origins and functional consequences of mitochondrial DNA mutations in human cancer
Joohon Sung Seoul National University, Korea RG4-4 Characteristics of apolipoprotein gene clusters on 11q23 and triglyceride levels in Asians
Research Group on Diabetes in Old Age : Frailty in diabetes
Thursday 13 October 15:00~17:00 | Place: Emerald Hall B
Chair: Hyung Joon Yoo
    • Aging is a significant driver of the diabetes epidemic. Although diabetes in older adults is linked to higher mortality and reduced functional status, we still do not know the risk of old diabetes. In this session, we focus on the pathogenesis of diabetes in the aging population.
      Professor Soo Lim (Seoul National University, Korea) is going to open the session by reviewing diabetes in aging population to help you to understand the elderly diabetes. Professor Jee Hyang Jeong (Ewha Womans University, Korea) will address cognitive impairment and Alzheimer’s disease resulting from elderly diabetes. Professor Jung Hyun Noh (Inje University, Korea) will present critical information regarding the frailty of elderly diabetes.
Soo Lim Seoul National University, Korea RG5-1 The applications of individualized health management system using advanced medical information technology in elderly patients with diabetes
Jee Hyang Jeong Ewha Womans University, Korea RG5-2 Diabetes, vascular cognitive impairment and AD
Jung Hyun Noh Inje University, Korea RG5-3 Frailty in diabetes
Research Group on Gestational Diabetes : Obesity & diabetes in pregnancy
Saturday 15 October 14:00~16:00 | Place: Convention hall A
Chair: Seok Won Park
    • The research group on gestational diabetes in Korean Diabetes Association set various topics related to obesity and diabetes in pregnancy. Four researchers who are actively conducting studies in this field were selected to share the latest information and their expertise in this session. Professor Ha Il Kim from KAIST, Korea, will present about β-cell adaptation in obesity and pregnancy. Professor Kyung-Soo Kim from CHA University, Korea, will give a lecture on how to predict and prevent gestational diabetes mellitus in obese women. Professor Min Hyoung Kim from Dankook University, Korea, will discuss whether gestational weight gain in normal and diabetic pregnancy is same or not. Dr. Kyung Wook Kim from Dongtan Jeil Womens Hospital, Korea, will summarize the studies for metformin use on pregnant women with obesity and diabetes.
Hail Kim KAIST, Korea RG6-1 β-cell adaptation in obesity and pregnancy
Kyung-Soo Kim CHA University, Korea RG6-2 Prediction and prevention of gestational diabetes mellitus in obese women
Min Hyoung Kim Dankook University, Korea RG6-3 Gestational weight gain in normal and diabetic pregnancy: it should be same or different?
Kyung Wook Kim Dongtan Jeil Womens Hospital, Korea RG6-4 Can metformin improve pregnancy outcomes in obese and diabetic women?
Quick Menu
Registration
Abstract
On-line submission
Venue
venue
Top